Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume

被引:50
作者
Terk, MR
Dardashti, S
Liebman, HA
机构
[1] Univ So Calif, Sch Med, Dept Radiol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Sch Med, Dept Med, Div Hematol, Los Angeles, CA 90033 USA
关键词
Gaucher disease; MRI; enzyme replacement therapy; liver; spleen; bone marrow;
D O I
10.1007/s002560000276
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Purpose. To determine whether T1-weighted magnetic resonance (MR) images can demonstrate response in the marrow of patients with type 1 Gaucher disease treated with enzyme replacement therapy (ERT) and to determine whether a relationship exists between liver and spleen volume reductions and visible marrow changes. Patients. Forty-two patients with type 1 Gaucher disease were evaluated on at least two occasions. Thirty-two patients received ERT. Of these patients, 15 had a baseline examination prior to the initiation of ERT. The remaining 10 patients did not receive ERT. Design. T1-weighted and gradient recalled echo (GRE) coronal images of the femurs and hips were obtained. Concurrently, liver and spleen volumes were determined using contiguous breath-hold axial gradient-echo images. T1-weighted images of the hips and femurs were evaluated to determine change or lack of change in the yellow marrow. Results. Of the 32 patients receiving ERT, 14 (44%) demonstrated increased signal on T1-weighted images suggesting an increase in the amount of yellow marrow. If only the 15 patients with a baseline examination were considered, the response rate to ERT was 67%. Using Student's t-test a highly significant correlation (P<0.005) was found between marrow response and reduction in liver and spleen volume. Conclusions. Marrow changes in patients receiving ERT can be detected by T1-weighted images. This response correlated with reductions in visceral volumes (P<0.0005).
引用
收藏
页码:563 / 571
页数:9
相关论文
共 23 条
[1]   Reconversion of bone marrow in Gaucher disease treated with enzyme therapy documented by MR [J].
Allison, JW ;
James, CA ;
Arnold, GL ;
Stine, KC ;
Becton, DL ;
Bell, JM .
PEDIATRIC RADIOLOGY, 1998, 28 (04) :237-240
[2]   Pulmonary involvement in adult Gaucher's disease: High resolution CT appearance [J].
Aydin, K ;
Karabulut, N ;
Demirkazik, F ;
Arat, A .
BRITISH JOURNAL OF RADIOLOGY, 1997, 70 :93-95
[3]   THERAPEUTIC RESPONSE TO INTRAVENOUS INFUSIONS OF GLUCOCEREBROSIDASE IN A PATIENT WITH GAUCHER DISEASE [J].
BARTON, NW ;
FURBISH, FS ;
MURRAY, GJ ;
GARFIELD, M ;
BRADY, RO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1913-1916
[4]  
BEUTLER E, 1991, NEW ENGL J MED, V325, P1354
[5]  
Brady R. O., 1983, METABOLIC BASIS INHE, P842
[6]   The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study [J].
Damiano, AM ;
Pastores, GM ;
Ware, JE .
QUALITY OF LIFE RESEARCH, 1998, 7 (05) :373-386
[7]   Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement [J].
Elstein, D ;
HadasHalpern, I ;
Itzchaki, M ;
Lahad, A ;
Abrahamov, A ;
Zimran, A .
BLOOD CELLS MOLECULES AND DISEASES, 1996, 22 (11) :104-111
[8]   UPTAKE AND DISTRIBUTION OF PLACENTAL GLUCOCEREBROSIDASE IN RAT HEPATIC CELLS AND EFFECTS OF SEQUENTIAL DEGLYCOSYLATION [J].
FURBISH, FS ;
STEER, CJ ;
KRETT, NL ;
BARRANGER, JA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 673 (04) :425-434
[9]   Enzyme therapy for Gaucher disease: the first 5 years [J].
Grabowski, GA ;
Leslie, N ;
Wenstrup, R .
BLOOD REVIEWS, 1998, 12 (02) :115-133
[10]  
HERMANN G, 1993, SKELETAL RADIOL, V22, P247